(How) Can We Prevent Type 2 Diabetes?
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
In the past 6 years, several randomized controlled trials have been conducted to test the impact of behavioral and pharmacological interventions on rates of development of type 2 diabetes in high-risk groups (1–7). The studies have demonstrated that it is possible to reduce the number of people who develop diabetes by 25–62% over 3- to 6-year time frames. As a result, discussions on mitigating the growing public health problem of type 2 diabetes have expanded from a relatively narrow focus on disease treatment to a broader focus on disease prevention. Ultimately, the broader focus is relevant to prevention and early treatment, both aimed at stabilization or reversal of an otherwise progressive disease process. Optimal strategies for disease modification at the stages of pre-diabetes and early diabetes remain to be defined. However, existing information is sufficient to begin to sort out the relative effectiveness of interventions and to make some recommendations for clinical care. In this article, I discuss both the concept of and evidence for diabetes prevention in the context of the biology of type 2 diabetes. I also suggest an approach for clinical care that is based on a combination of knowledge about disease biology and the results of clinical trials. Hyperglycemia results from an insulin supply that is insufficient to meet the body's needs. Diabetes is hyperglycemia that exceeds the threshold where the risk of diabetic retinopathy is currently thought to begin. In type 2 diabetes, insufficient insulin supply occurs in a setting of increased insulin demands—chronic insulin resistance. Longitudinal studies of insulin secretion and insulin action in Pima Indians (8), Hispanic women with prior gestational diabetes (9), and Hispanic, white, and African-American participants in the Insulin Resistance Atherosclerosis Study (10) reveal that abnormalities in insulin secretion and action are present long before type 2 diabetes …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
Impaired Fasting Glucose and Impaired Glucose Tolerance
Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., & Zinman, B. (2007) · Diabetes Care · doi:10.2337/dc07-9920 · Cited by 1,396
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Self-citationEffect of ramipril on the incidence of diabetes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737
Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1133 · Cited by 540
Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program
The Diabetes Prevention Program Research Group* (2005) · Diabetes · doi:10.2337/diabetes.54.4.1150 · Cited by 474
Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Kawakubo, M., & Buchanan, T. A. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1066 · Cited by 402 · cited 1×
“5 years of treatment in the Pioglitazone in Prevention of Diabetes (PIPOD) study (17).”
BackgroundSelf-citationThe Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.4.977 · Cited by 218
Goldfine, A. B., Bouche, C., Parker, R. A., Kim, C., Kerivan, A., Soeldner, J. S., Martin, B. C., Warram, J. H., & Kahn, C. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438009100 · Cited by 99
Cited by
Cusi, K. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 911
Gestational Diabetes Mellitus: Risks and Management during and after Pregnancy
Buchanan, T. A., Xiang, A. H., & Page, K. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.96 · Cited by 718
Self-citationThe Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes
Cusi, K. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0122-6 · Cited by 300
Glucose challenge test screening for prediabetes and undiagnosed diabetes
Phillips, L. S., Ziemer, D. C., Kolm, P., Weintraub, W. S., Vaccarino, V., Rhee, M. K., Chatterjee, R., Narayan, K. M. V., & Koch, D. D. (2009) · Diabetologia · doi:10.1007/s00125-009-1407-7 · Cited by 67
Morris, R. T., Laye, M. J., Lees, S. J., Rector, R. S., Thyfault, J. P., & Booth, F. W. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01034.2007 · Cited by 56
“delay in the onset of Type 2 diabetes (8).”
Background
Metadata
- Authors
- Buchanan, T. A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-06-01
- Volume
- 56
- Issue
- 6
- Pages
- 1502-1507
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2113246605
- Cited by
- 55
- References
- 15
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.